Glutamine
Glutamine is a **conditionally essential amino acid** that plays a critical role in maintaining the health and integrity of the gastrointestinal (GI) tract, immune system, kidneys, and liver. While healthy animals with adequate dietary protein intake synthesize sufficient glutamine in their skeletal muscles, patients under severe metabolic stress (such as those with critical illness, severe trauma, or undergoing chemotherapy) may consume more glutamine than they can produce. This depletion can lead to progressive muscle wasting and compromise the intestinal mucosal barrier, resulting in atrophy, ulceration, or necrosis of the intestinal epithelium. **Clinical Highlights:** - Primarily used as a **GI protectant** and to promote mucosal healing in conditions like parvoviral enteritis, chemotherapy-induced enteritis, and pancreatitis. - **Clinical Pearl:** Glutamine is the preferred respiratory fuel for enterocytes (intestinal absorptive cells) and colonocytes. Supplementation aims to directly nourish these cells and maintain the gut barrier function, preventing bacterial translocation. - Generally very safe with a wide margin of safety, though clinical efficacy data in veterinary medicine remains mixed (e.g., some studies show no significant benefit in methotrexate-induced enteritis in cats).
Mecanismo: Glutamine serves multiple vital physiological functions: - **Enterocyte Fuel:** It is the primary metabolic fuel for rapidly dividing cells, particularly intestinal enterocytes and immune cells (lymphocytes, macrophages). Glutamine is metabolized via **glutaminase** to glutamate, which is then converted to alpha-ketoglutarate to enter the **TCA (Krebs) cycle** for ATP production. - **Precursor Molecule:** It acts as a crucial nitrogen donor and precursor for the synthesis of **glutathione** (a major intracellular antioxidant), purines, pyrimidines, and other amino acids. - **Mucosal Integrity:** By providing direct energy to the gut lining, it stimulates intestinal cell proliferation and differentiation, helping to maintain tight junctions and prevent increased intestinal permeability ("leaky gut") during times of severe stress or mucosal injury.
Dosificación por especie
- Adjunctive treatment of GI inflammatory conditions · 0.5 grams/kg PO daily · PO · q24h
- Adjunctive treatment of GI inflammatory conditions · 0.5 gram/kg/day PO divided twice a day · PO · q12h · Administer in water or food
- Adjunctive treatment of GI inflammatory conditions (for animals not eating) · 0.5 grams/kg per day divided into 2-3 doses · PO · q8-12h · Dissolved in drinking water
- Adjunctive treatment of GI inflammatory conditions · 0.5 grams/kg PO daily · PO · q24h
- Adjunctive treatment of GI inflammatory conditions · 0.5 gram/kg/day PO divided twice a day · PO · q12h · Administer in water or food
- Adjunctive treatment of GI inflammatory conditions (for animals not eating) · 0.5 grams/kg per day divided into 2-3 doses · PO · q8-12h · Dissolved in drinking water
Las dosis son una referencia clínica para veterinarios colegiados. Confirme siempre con la ficha técnica vigente y el paciente individual.
Vías de administración
Contraindicaciones
- Severe hepatic insufficiency
- Severe behavior disorders
- Epilepsy or seizure disorders
Efectos adversos
- Generally well tolerated
- Potential CNS effects at very high dosages
- Increased serum ammonia or glutamate levels
Interacciones farmacológicas
- Anticonvulsant medications (e.g., phenobarbital, potassium bromide) · Glutamine could potentially decrease the efficacy of antiseizure medications because it is partially converted into glutamate, which acts as an excitatory neurotransmitter in the CNS.
- Lactulose · Theoretically, glutamine may antagonize the ammonia-lowering effects of lactulose in patients being treated for hepatic encephalopathy.
Monitorización
- Clinical efficacy (improvement in GI signs, weight maintenance)
- Serum ammonia levels (in patients with compromised liver function)
- Serum glutamate levels
Sobredosis
Overdosages are unlikely to be harmful in healthy animals. In humans, intravenous doses of up to 40 grams per day have been tolerated without ill effects. However, because glutamine is partially metabolized to ammonia, patients with pre-existing hepatic insufficiency (liver disease) may be adversely affected and could develop signs of hepatic encephalopathy.
La referencia de fármacos de VetSheet está destinada a veterinarios colegiados como apoyo a la decisión clínica, no sustituye el juicio profesional ni la ficha técnica vigente del fabricante.